AIM ImmunoTech Inc. Share Price

AIM ImmunoTech Inc. Share Price

AMEX: AIM | Micro Cap
$0.14
-$0.01 (-5.01%) Last updated on 17 Nov, 2026 | 02:29 IST
  • Performance
  • Chart
  • Fundamentals
  • Quarterly P&L
  • Annual P&L
  • About
  • Price history
  • FAQs

AIM ImmunoTech Inc. Stock Performance

Open
$0.14
Prev. Close
$0.14
Circuit Range
N/A
Day Range
$0.13 - $0.14
Year Range
$0.13 - $1.79
Volume
5,002
Average Traded
$0.14

AIM ImmunoTech Inc. Share Price Today

As of 17 November 2026, AIM ImmunoTech Inc.'s share price is $0.14. The stock opened at $0.14, compared to its previous close of $0.14. During today's trading session, AIM ImmunoTech Inc.'s share price traded between $0.13 and $0.14, with an average price of $0.14. Over the past 52 weeks, the stock has recorded a high of $1.79 and a low of $0.13. In terms of performance, AIM ImmunoTech Inc.'s share price has declined by 66.87% over the last six months and is down 90.99% on a year-on-year basis.

AIM ImmunoTech Inc. Share Price Chart

Line chart of the AIM ImmunoTech Inc. price trend over the selected period. The price fell overall, ranging from 0.13 to 0.14, ending at 0.14.
$0.13$0.14
L
Show Current Price
H

AIM ImmunoTech Inc. Stock Fundamentals & Key Indicators

Market Cap
$220941.22
PE Ratio (TTM)
N/A
Dividend Yield
0.00%
EPS (TTM)
$-0.43
Revenue (TTM)
$90.00M
Return On Equity (TTM)
-244.90%
Profit Margin
-15511.11%
Debt to Equity
0.20
Quarterly Earnings Growth YoY
24.88%

AIM ImmunoTech Inc. Quarterly Profit & Loss

All figures in USD

ParticularsDec 2025Mar 2026Jun 2026Sep 2026
Revenue$0.02$0.02$0.03$0.02
Net Profit-$4.18-$3.02-$6.99-$3.14
Net Profit Margin-20900.00%-15100.00%-23300.00%-15700.00%
Income ChangeN/A27.75%-131.46%55.08%

AIM ImmunoTech Inc. Annual Profit & Loss

All figures in USD

Particulars2022202320242025
Revenue$0.14$0.20$0.17$0.09
Net Profit-$19.45-$28.96-$17.32-$13.96
Net Profit Margin-13892.86%-14480.00%-10188.24%-15511.11%
Income ChangeN/A-48.89%40.19%19.40%

About AIM ImmunoTech Inc.

AIM ImmunoTech Inc is an immuno-pharma company focused on the research and development of therapeutics to treat multiple types of cancers, viral diseases, and immune-deficiency disorders, and to treat cancers for which there are currently inadequate or unmet therapies. Its flagship products are Ampligen (rintatolimod) and Alferon N Injection (Interferon alfa). Ampligen is a double-stranded RNA (dsRNA) molecule being developed for globally important cancers, viral diseases, and disorders of the immune system. Ampligen is approved for commercial sale in the Argentine Republic for the treatment of severe Chronic Fatigue Syndrome (CFS).

AIM ImmunoTech Inc. Historical Returns

Share price history by day, with open and close prices and the day's change
MonthOpenCloseChange %
Nov 2026
$0.16
$0.14
-12.82%
Oct 2026
$0.17
$0.16
-11.36%
Sep 2026
$0.24
$0.18
-30.71%
Aug 2026
$0.26
$0.25
-1.17%
Jul 2026
$0.28
$0.26
-7.55%
Jun 2026
$0.56
$0.28
-32.52%
May 2026
$0.53
$0.41
-21.22%
Apr 2026
$0.60
$0.52
-6.10%
Mar 2026
$0.93
$0.56
-38.38%
Feb 2026
$1.11
$0.90
-24.67%
Jan 2026
$1.20
$1.20
+8.11%
Dec 2025
$1.59
$1.11
-26.73%

AIM Share Price FAQs